Insider Trading & Ownership - Wolff Stefani

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Wolff Stefani
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-05-01
Sale
2023-05-02
4:33 pm
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
342$9.8763$3,37816,695
(Direct)
View
2023-01-30
Sale
2023-02-01
4:18 pm
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
424$11.78$4,99515,484
(Direct)
View
2022-10-31
Sale
2022-11-01
7:32 pm
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
350$12.88$4,50815,908
(Direct)
View
2022-08-01
Sale
2022-08-02
5:48 pm
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
356$15.67$5,57914,706
(Direct)
View
2022-05-02
Sale
2022-05-03
7:04 pm
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
330$11.75$3,87815,062
(Direct)
View
2020-06-15
Sale
2020-06-17
9:52 pm
Principia Biopharma Inc.PRNBWolff Stefani
Chief Development Officer
5,504$60.75$334,38519,096
(Direct)
View
2020-03-16
Sale(A)
2020-06-17
9:48 pm
Principia Biopharma Inc.PRNBWolff Stefani
Chief Development Officer
5,504$46.15$254,03124,600
(Direct)
View
2019-12-16
Sale(A)
2020-06-17
9:41 pm
Principia Biopharma Inc.PRNBWolff Stefani
Chief Development Officer
5,505$49.43$272,09130,104
(Direct)
View
2020-03-16
Sale
2020-03-18
5:08 pm
Principia Biopharma Inc.PRNBWolff Stefani
Chief Development Officer
5,504$46.15$254,03154,656
(Direct)
View
2019-12-16
Sale
2019-12-18
7:09 pm
Principia Biopharma Inc.PRNBWolff Stefani
Chief Development Officer
5,505$49.43$272,09160,160
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-26
Disposition
2024-01-26
4:50 pm
N/A
N/A
Rain Oncology Inc.RAINWolff Stefani
Director
79,000$00
(Direct)
View
2023-08-09
Option Award
2023-08-11
9:09 pm
N/A
2033-08-09
Rain Oncology Inc.RAINWolff Stefani
Director
35,000$035,000
(Direct)
View
2023-04-30
Exercise
2023-05-02
4:33 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
962$016,695
(Direct)
View
2023-02-14
Option Award
2023-02-15
4:14 pm
N/A
2033-02-13
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
112,900$0112,900
(Direct)
View
2023-01-30
Exercise
2023-02-01
4:18 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
962$015,484
(Direct)
View
2022-10-30
Exercise
2022-11-01
7:32 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
962$015,908
(Direct)
View
2022-06-01
Option Award
2022-08-19
5:38 pm
N/A
2032-06-01
Rain Therapeutics Inc.RAINWolff Stefani
Director
20,000$020,000
(Direct)
View
2022-08-09
Option Award
2022-08-10
4:18 pm
N/A
2032-08-08
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
110,375$0110,375
(Direct)
View
2022-07-30
Exercise
2022-08-02
5:48 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
962$014,706
(Direct)
View
2022-04-30
Exercise
2022-05-03
7:04 pm
N/A
N/A
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
962$015,062
(Direct)
View
2022-01-19
Option Award
2022-01-21
4:17 pm
N/A
2032-01-18
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
50,023$050,023
(Direct)
View

Ownership
2021-08-17
5:19 pm
N/A
2031-07-12
Nurix Therapeutics Inc.NRIXWolff Stefani
EVP and COO
0$0443,865
(Direct)
View
2021-05-14
Option Award
2021-05-18
5:44 pm
N/A
2031-05-14
Rain Therapeutics Inc.RAINWolff Stefani
Director
24,000$024,000
(Direct)
View
2020-09-18
Gift
2020-09-28
5:19 pm
N/A
N/A
Principia Biopharma Inc.PRNBWolff Stefani
Chief Development Officer
5,504$00
(Direct)
View
2020-09-28
Equity Swap
2020-09-28
5:19 pm
N/A
N/A
Principia Biopharma Inc.PRNBWolff Stefani
Chief Development Officer
13,592$1000
(Direct)
View
2020-09-28
Disposition
2020-09-28
5:19 pm
N/A
2027-02-15
Principia Biopharma Inc.PRNBWolff Stefani
Chief Development Officer
238,958$00
(Direct)
View
2020-03-16
Exercise
2020-03-18
5:08 pm
N/A
2027-02-15
Principia Biopharma Inc.PRNBWolff Stefani
Chief Development Officer
5,504$054,656
(Direct)
View
2020-03-16
Exercise
2020-03-18
5:08 pm
N/A
N/A
Principia Biopharma Inc.PRNBWolff Stefani
Chief Development Officer
5,504$4.54254,656
(Direct)
View
2020-03-05
Option Award
2020-03-05
5:30 pm
N/A
2030-03-04
Principia Biopharma Inc.PRNBWolff Stefani
Chief Development Officer
55,000$055,000
(Direct)
View
2019-12-16
Exercise
2019-12-18
7:09 pm
N/A
2027-02-15
Principia Biopharma Inc.PRNBWolff Stefani
Chief Development Officer
5,505$060,160
(Direct)
View
2019-12-16
Exercise
2019-12-18
7:09 pm
N/A
N/A
Principia Biopharma Inc.PRNBWolff Stefani
Chief Development Officer
5,505$4.54260,160
(Direct)
View
(A) Indicate amendment filing.